|
- MedAccess
Over two billion people can’t access the medicines they need, causing preventable illness, disease and death MedAccess is here to change that
- What we do - MedAccess
We increase access to medical innovations Our agreements accelerate access to health products that can save and protect lives We analyse markets across a range of health areas, identifying opportunities to increase access to products in countries where they are unavailable or unaffordable
- Meet the team and Board - MedAccess
Led by Professor Helen Rees, the MedAccess Board is responsible for our oversight and governance Board members bring expertise and experience in finance, the healthcare industry, and global public health
- Careers - MedAccess
Receive regular updates about how our innovative finance work is making healthcare products more affordable and accessible Everyone at MedAccess has an impact on our mission, whatever their role Find out more about careers at MedAccess today
- Our innovative finance products - MedAccess
We tailor our market shaping interventions to address specific access barriers, such as high prices, poor product availability, and insufficient supply When our financial tools can help unlock access to a medical innovation, we construct partnerships that enable us to achieve sustainable impact
- Latest news - MedAccess
Receive regular updates about how our innovative finance work is making healthcare products more affordable and accessible Find out more about our work by reading our latest news stories, press releases, statements and insight articles
- MedAccess becomes founding partner of G7 initiative for impact . . .
It aims to galvanise impact investors to target investments that promote equitable access to medicines and support global action on Universal Health Coverage (UHC) The initiative will focus initially on deepening knowledge and sharing examples of successful impact investing for health
- MedAccess Trust
MedAccess Trust is a charity that aims to raise funds and help improve affordability and access to healthcare in low- and middle-income countries
|
|
|